281 related articles for article (PubMed ID: 32440154)
1. The Role of DLLs in Cancer: A Novel Therapeutic Target.
Xiu MX; Liu YM; Kuang BH
Onco Targets Ther; 2020; 13():3881-3901. PubMed ID: 32440154
[TBL] [Abstract][Full Text] [Related]
2. Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma.
Song HY; Wang Y; Lan H; Zhang YX
Exp Ther Med; 2018 Jul; 16(1):53-60. PubMed ID: 29896227
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes.
Zhang J; Gao H; Zhang Y
Oncol Lett; 2017 Jun; 13(6):4533-4539. PubMed ID: 28599454
[TBL] [Abstract][Full Text] [Related]
4. A cell autonomous role for the Notch ligand Delta-like 3 in αβ T-cell development.
Hoyne GF; Chapman G; Sontani Y; Pursglove SE; Dunwoodie SL
Immunol Cell Biol; 2011 Aug; 89(6):696-705. PubMed ID: 21151194
[TBL] [Abstract][Full Text] [Related]
5. Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
Bettinsoli P; Ferrari-Toninelli G; Bonini SA; Prandelli C; Memo M
BMC Cancer; 2017 May; 17(1):352. PubMed ID: 28525978
[TBL] [Abstract][Full Text] [Related]
6. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.
Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J
Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
Kumar S; Srivastav RK; Wilkes DW; Ross T; Kim S; Kowalski J; Chatla S; Zhang Q; Nayak A; Guha M; Fuchs SY; Thomas C; Chakrabarti R
Oncogene; 2019 Mar; 38(12):2092-2107. PubMed ID: 30442981
[TBL] [Abstract][Full Text] [Related]
8. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
9. Role of recycling, Mindbomb1 association, and exclusion from lipid rafts of δ-like 4 for effective Notch signaling to drive T cell development.
Shah DK; Mohtashami M; Zúñiga-Pflücker JC
J Immunol; 2012 Dec; 189(12):5797-808. PubMed ID: 23162128
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
11. Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.
Geffers I; Serth K; Chapman G; Jaekel R; Schuster-Gossler K; Cordes R; Sparrow DB; Kremmer E; Dunwoodie SL; Klein T; Gossler A
J Cell Biol; 2007 Jul; 178(3):465-76. PubMed ID: 17664336
[TBL] [Abstract][Full Text] [Related]
12. Feedback loops comprising Dll1, Dll3 and Mesp2, and differential involvement of Psen1 are essential for rostrocaudal patterning of somites.
Takahashi Y; Inoue T; Gossler A; Saga Y
Development; 2003 Sep; 130(18):4259-68. PubMed ID: 12900443
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity?
Kumar A; Desai S; Pandey BN
Transl Lung Cancer Res; 2013 Dec; 2(6):439-41. PubMed ID: 25806265
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.
Ferreira A; Lamy M; Margarida Rocha M; Silva G; Bandeiras TM; Barbas A
Protein Expr Purif; 2018 Jun; 146():8-16. PubMed ID: 29366964
[TBL] [Abstract][Full Text] [Related]
15. O-fucosylation of DLL3 is required for its function during somitogenesis.
Serth K; Schuster-Gossler K; Kremmer E; Hansen B; Marohn-Köhn B; Gossler A
PLoS One; 2015; 10(4):e0123776. PubMed ID: 25856312
[TBL] [Abstract][Full Text] [Related]
16. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
17. Possible roles of DLK1 in the Notch pathway during development and disease.
Falix FA; Aronson DC; Lamers WH; Gaemers IC
Biochim Biophys Acta; 2012 Jun; 1822(6):988-95. PubMed ID: 22353464
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract][Full Text] [Related]
19. Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome.
Shaik JP; Alanazi IO; Pathan AAK; Parine NR; Almadi MA; Azzam NA; Aljebreen AM; Alharbi O; Alanazi MS; Khan Z
J Oncol; 2020; 2020():6768942. PubMed ID: 32211044
[TBL] [Abstract][Full Text] [Related]
20. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.
Wood S; Feng J; Chung J; Radojcic V; Sandy-Sloat AR; Friedman A; Shelton A; Yan M; Siebel CW; Bishop DK; Maillard I
J Immunol; 2015 Mar; 194(6):2899-908. PubMed ID: 25687759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
